Paul Cherukuri

Adjunct Professor of Management – Entrepreneurship

Dr. Cherukuri is the Executive Director of the Institute of Biosciences and Bioengineering at Rice University where he develops and implements bio-related cross-disciplinary research, education, and innovation projects between Rice and the Texas Medical Center. In addition, the Cherukuri research group studies electrodynamic properties of nanoscale and biological materials aimed at developing solutions for global problems in energy and health. His discovery of Teslaphoresis has received wide acclaim by the scientific community (e.g. ACS Editors’ Choice) and national media (e.g. Wired Magazine, IEEE Spectrum) as a breakthrough technique in nanotechnology with potential applications ranging from material science to medicine.

Prior to his current role at Rice, Dr. Cherukuri was a senior scientist at Sanofi (Chattem, Inc.) where he managed the R&D of numerous top-selling drug products (e.g. Allegra). Prior to joining Sanofi, he was a visiting scholar at Harvard University with Prof. George Whitesides and a Research Assistant Professor of Experimental Therapeutics at the University of Texas MD Anderson Cancer Center. His pioneering work on targeted cancer therapy using radiofrequency heating of metal nanoparticles (featured on 60 Minutes) is now in pre-clinical trials.

Dr. Cherukuri earned a B.S. in physics from the University of Kentucky and a Ph.D. in physical chemistry at Rice University under the supervision of Nobel Laureate, Prof. Richard E. Smalley and R. Bruce Weisman. He is a subject matter expert in nanotechnology, drug development, biomedical devices and technology commercialization. His unique background in the forefront of academic and industry research gives him critical insight to drive innovative solutions into the marketplace.